The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Values and Limitations of 18F-Fluorodeoxyglucose???Positron-Emission Tomography with Preoperative Evaluation of Patients with Pancreatic Masses
Abstract
The aim of this study was to determine the value and limitations of 18F-fluorodeoxyglucose (FDG)-position-emission tomography (PET) for differentiating benign and malignant pancreatic disease and for staging malignant disease. One hundred fifty-nine patients with 89 malignant and 70 benign pancreatic lesions all received PET, computed tomography (CT), and endoscopic retrograde cholangiopancreatography (ERCP) before pancreatic surgery. The original reports were compared for all patients (group I; N = 159), for a subgroup that neither had fasting plasma glucose levels > or =130 mg/dL or known elevated levels of C-reactive protein ([CRP], group II; n = 123), and for the remaining patients (group III; n = 36). For group I, accuracy values (areas under receiver operating characteristic [ROC] curves) for differentiation of benign/malignant masses were 0.86 (PET), 0.93 (ERCP), 0.82 (CT), and 0.95 for ERCP + PET (N = 159). For group II, ROC areas increased to 0.92 (PET), 0.94 (p < 0.05; n = 123) (ERCP), 0.82 (CT), 0.97 (p < 0.05; n = 123) (ERCP + PET). The results for group III were 0.71 (PET), 0.81 (CT), and 0.93 (ERCP); (n = 36). With 54 patients of group II that either had contradictory or indeterminate/technically unsuccessful CT/ERCP, PET was correct in 43 patients (84%). Sensitivity/specificity for lymph node staging was 49%/63%, respectively. For patients with hepatic metastasis, PET was 70% sensitive and 95% specific, missing some metastasis that were <1 cm. PET detected peritoneal metastasis in 25% of patients, missing poorly localized microscopic spread. For selected patients who have indeterminate pancreatic masses but no hyperglycemia or serologic evidence of active inflammation, FDG-PET is an independent functional assay that significantly adds to the diagnostic accuracy of ERCP and CT in the differentiation of benign and malignant pancreatic disease. PET can reliably detect hepatic, peritoneal, and other distant metastases that are > or =1 cm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bares, R., Klever, P., Hauptmann, S., Hellwig, D., Fass, J., Cremerius, U., Schumpelick, V, Mittermayer, C., & Büll, U. (1994) · Radiology · doi:10.1148/radiology.192.1.8208970 · Cited by 213
Cited by
Antoch, G., Saoudi, N., Kuehl, H., Dahmen, G., Mueller, S. P., Beyer, T., Bockisch, A., Debatin, J. F., & Freudenberg, L. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.120 · Cited by 435
Heinrich, S., Goerres, G. W., Schäfer, M., Sagmeister, M., Bauerfeind, P., Pestalozzi, B. C., Hany, T. F., von Schulthess, G. K., & Clavien, P.-A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000172095.97787.84 · Cited by 321
Kauhanen, S. P., Komar, G., Seppänen, M. P., Dean, K. I., Minn, H. R., Kajander, S. A., Rinta-Kiikka, I., Alanen, K., Borra, R. J., Puolakkainen, P. A., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b2fafa · Cited by 317
Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F. (2001) · Hepatology · doi:10.1053/jhep.2001.23912 · Cited by 265
Metadata
- Authors
- Diederichs, C. G., Staib, L., Vogel, J., Glasbrenner, B., Glatting, G., Brambs, H.-J., Beger, H. G., & Reske, S. N.
- Venue
- Pancreas
- Published
- 2000-03
- Volume
- 20
- Issue
- 2
- Pages
- 109-116
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2019521878
- Cited by
- 167
- References
- 1
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Values and Limitations of 18F-Fluorodeoxyglucose???Positron-Emission Tomography with Preoperative Evaluation of Patients with Pancreatic Masses. https://app.cochat.ai/papers/10.1097/00006676-200003000-00001
- The paper
- Diederichs, C. G., Staib, L., Vogel, J., Glasbrenner, B., Glatting, G., Brambs, H.-J., Beger, H. G., & Reske, S. N. (2000). Values and Limitations of 18F-Fluorodeoxyglucose???Positron-Emission Tomography with Preoperative Evaluation of Patients with Pancreatic Masses. Pancreas. https://doi.org/10.1097/00006676-200003000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.